Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Financings in Brief: Vision Sciences

This article was originally published in The Gray Sheet

  • News

Executive Summary

Vision Sciences: Chairman, CEO and President Katsumi Oneda and Vice Chairman Lewis Pell agree to buy $2 mil. each of common stock in the company, which manufactures infection control products for endoscopy. Oneda and Pell, each of whom currently own 14% of the company, will buy the shares on Dec. 27, 1995 for "a price equal to the average closing price for the ten trading days ending Dec. 26, 1995," the firm says...

Table

View full table

Tags:
Latest Headlines

MHRA Sets Out Summer Schedule Of Medtech Regulatory Milestones

Apple Watch Feature Qualified As FDA Device Development Tool

Expert Proposes AI Device Reimbursement Model ‘Like Netflix’

Robotic-Assisted Treatment For Enlarged Prostate Shows Promising Results

See All
UsernamePublicRestriction

Register

MT005167

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By